Cargando…
Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus first identified in late 2019 and subsequently declared a worldwide pandemic in March 2020. In this review, we provide an overview of the implications of SARS-CoV-2 for blood safety and sufficiency....
Autores principales: | Kiely, Philip, Hoad, Veronica C., Seed, Clive R., Gosbell, Iain B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059091/ https://www.ncbi.nlm.nih.gov/pubmed/35528142 http://dx.doi.org/10.1159/000522264 |
Ejemplares similares
-
An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety?
por: Hoad, Veronica C., et al.
Publicado: (2022) -
Risk of variant Creutzfeldt–Jakob disease transmission by blood transfusion in Australia
por: McManus, Hamish, et al.
Publicado: (2022) -
Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk
por: Kiely, Philip, et al.
Publicado: (2017) -
Severe Acute Respiratory Syndrome : An Update
por: Mehta, SR, et al.
Publicado: (2007) -
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
por: Pal, Mahendra, et al.
Publicado: (2020)